The Pediatric Clinical Trials Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Pediatric Clinical Trials Global Market Report 2025 has seen robust growth recently. It is projected to increase from $17.41 billion in 2024 to $18.45 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%.
The Pediatric Clinical Trials Global Market is forecasted to reach a value of $24.8 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 7.7%.
Download Your Free Sample of the 2025 Pediatric Clinical Trials Market Report and Uncover Key Trends Now!The key drivers in the pediatric clinical trials market are:
• Integration of real-world evidence into pediatric clinical trials
• The discovery of pediatric biomarkers
• The expansion of access programs in the market
• Advancements in pediatric infectious diseases research and cardiology.
The pediatric clinical trials market covered in this report is segmented –
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Treatment Studies, Observational Studies
3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas
The key trends in the pediatric clinical trials market are:
• One emerging trend is the increased use of patient-centric trial design in pediatric clinical trials.
• The adoption of adaptive trial designs is also shaping the future of this market.
• The incorporation of digital health technologies is increasingly prevalent in pediatric clinical trials.
• Global collaboration and consortia are becoming increasingly significant in this field.
The major players in the pediatric clinical trials market are:
• Medpac Inc
North America was the largest region in the pediatric clinical trials market in 2024